Related Experiment Video

Updated: Jun 14, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Adenovirus vaccine immunotherapy targeting WT1-expressing tumors

Jeffrey M Clarke1, Michael A Morse, H Kim Lyerly

  • 1Department of Medicine, Duke University Medical Center, DUMC Box 31379, Durham, NC 27710, USA. jeffrey.clarke@duke.edu

Expert Opinion on Biological Therapy
|April 13, 2010
PubMed
Abstract

Insights

Ad-WT1 immunotherapy, using a recombinant adenovirus, effectively targets Wilm's Tumor gene (WT1) to stimulate T cell responses and inhibit tumor growth, showing promise for cancer treatment.

Area of Science:

  • Immunotherapy
  • Oncology
  • Viral Vector Technology

Background:

  • Tumor-associated antigens (TAAs) are key targets for cancer immunotherapy.
  • Viral vectors encoding TAAs are emerging vaccination strategies.
  • Wilm's Tumor gene (WT1) is a TAA overexpressed in many cancers, leading to Ad-WT1 development.

Purpose of the Study:

  • To review the development of Ad-WT1 immunotherapy.
  • To summarize preclinical and clinical evidence for WT1-based vaccines and adenoviral vectors.
  • To highlight Ad-WT1's potential in antitumor therapy.

Main Methods:

  • Review of preclinical studies and clinical trials.
  • Analysis of WT1-based vaccines and TAA-expressing adenoviral vectors.
  • Examination of Ad-WT1's in vivo antitumor effects.

Main Results:

  • WT1-based vaccines possess fundamental immunogenic properties.
  • Adenoviral vectors effectively elicit TAA-specific immune responses.
  • Evidence supports Ad-WT1's efficacy in inhibiting tumor growth in vivo.

Conclusions:

  • Ad-WT1 induces robust CD4(+) and CD8(+) T cell responses.
  • Ad-WT1 demonstrates significant in vivo tumor growth inhibition.
  • Ad-WT1 represents a promising cancer therapy for further investigation.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction10:18

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...